Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not — Stella

Home/Pancreatic Neuroendocrine Tumor/

View on ClinicalTrials.gov

Recruiting

Back to Pancreatic Neuroendocrine Tumor trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

Sweden

Sahlgrenska University Hospital, Gothenburg

Skåne University Hospital, Lund

Karolinska University Hospital, Stockholm

Uppsala University Hospital, Uppsala

Key details

Sponsor

Uppsala University

Collaborators

Uppsala Clinical Research Center, Sweden

Enrollment target

~200 participants

Started

January 2026

Primary completion

May 2033

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.